Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders

Marion Le Meur1, Jaime Pignatelli2, Paolo Blasi3

  • 1Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), 28049 Madrid, Spain; Dipartimento di Farmacia e Biotecnologie (FaBiT), Alma Mater Studiorum - Università di Bologna, 40127 Bologna, Italy.

PubMed
Summary

Nanoparticles offer a promising solution for treating neurological disorders linked to circadian clock dysfunction by improving drug delivery to the brain and enabling timed release therapies.